Showing results (51-60 of 5,338) with videos related to
Sort By:
Pageof 534
Japanese Journal of Clinical Oncology|February 24, 2019
Patient preference study comparing hypofractionated versus conventionally fractionated whole-breast irradiation after breast-conserving surgeryHiroki Kawaguchi, Kayoko Tsujino, Mayuko Miki, et al.Japanese Journal of Clinical Oncology|February 28, 2019
Plasma ctDNA monitoring during epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitor treatment in patients with EGFR-mutant non-small cell lung cancer (JP-CLEAR trial)Kazuhiro Usui, Takuma Yokoyama, Go Naka, et al.Japanese Journal of Clinical Oncology|September 11, 2019
Long-term outcome, relapse patterns, and toxicity after radiotherapy for orbital mucosa-associated lymphoid tissue lymphoma: implications for radiotherapy optimizationJeongshim Lee, Jin Sook Yoon, Jin-Seok Kim, et al.Japanese Journal of Clinical Oncology|February 2, 2021
Death by suicide, other externally caused injuries and cardiovascular diseases within 6 months of cancer diagnosis (J-SUPPORT 1902)Saki Harashima, Maiko Fujimori, Tatsuo Akechi, et al.Japanese Journal of Clinical Oncology|January 14, 2021
Surgical outcomes of primary lung cancers following esophagectomy for primary esophageal carcinomaHiroaki Komatsu, Nobuhiro Izumi, Takuma Tsukioka, et al.Japanese Journal of Clinical Oncology|August 27, 2020
Barriers to end-of-life discussion with advanced cancer patient as perceived by oncologists, certified/specialized nurses in cancer nursing and medical social workersYasutaka Kimura, Miki Hosoya, Kyoko Toju, et al.Japanese Journal of Clinical Oncology|August 27, 2020
EML4-ALK, a potential therapeutic target that responds to alectinib in ovarian cancerBeina Hui, Jingping Zhang, Xiaobo Shi, et al.Japanese Journal of Clinical Oncology|January 30, 2014
Superior tolerability of altered dosing schedule of sunitinib with 2-weeks-on and 1-week-off in patients with metastatic renal cell carcinoma--comparison to standard dosing schedule of 4-weeks-on and 2-weeks-offTsunenori Kondo, Toshio Takagi, Hirohito Kobayashi, et al.Japanese Journal of Clinical Oncology|January 30, 2014
Antiangiogenesis therapy for breast cancer: an update and perspectives from clinical trialsElham Fakhrejahani, Masakazu ToiJapanese Journal of Clinical Oncology|October 15, 2009
Therapeutic effect of linac-based stereotactic radiotherapy with a micro-multileaf collimator for the treatment of patients with brain metastases from lung cancerJun-ichi Saitoh, Yoshihiro Saito, Tomoko Kazumoto, et al.Pageof 534